Center for the Study of Drug Development, Tufts University School of Medicine, Boston, Massachusetts.
Clin Ther. 2017 Nov;39(11):2203-2213. doi: 10.1016/j.clinthera.2017.09.014. Epub 2017 Oct 25.
The Tufts Center for the Study of Drug Development conducted a study among practicing physicians and nurses (health care providers) across multiple specialties to assess their attitudes and experiences with referring patients into clinical trials and to supplement the body of scholarly research focused primarily on referral practices among oncology-based health care providers.
A total of 755 physicians and 1255 nurses completed online surveys in late 2015 and early 2016.
The results of the study indicate that a high percentage of multispecialty nurses and physicians is interested in referring their patients to appropriate clinical trials, are familiar with the clinical trial process, and are comfortable providing clinical trial information to, and discussing clinical trial opportunities with, their patients. Study results also indicate, however, that health care providers refer only a small number of patients each year largely because of the inability to access clinical trial information and the lack of sufficient information and time to evaluate and confidently discuss clinical trial options with their patients.
Many reasons for choosing not to refer patients appear addressable, particularly through effective but presently -underused communication leveraging social media communities and using liaisons who can act as a bridge between clinical care and clinical research.
塔夫茨药物开发研究中心在多个专业的执业医师和护士(医疗保健提供者)中进行了一项研究,以评估他们对将患者转介到临床试验中的态度和经验,并补充主要集中在以肿瘤学为基础的医疗保健提供者的转介实践的学术研究。
共有 755 名医生和 1255 名护士于 2015 年底和 2016 年初完成了在线调查。
研究结果表明,相当比例的多专科护士和医生有兴趣将其患者转介到适当的临床试验中,熟悉临床试验过程,并愿意向患者提供临床试验信息,并与患者讨论临床试验机会。然而,研究结果还表明,医疗保健提供者每年仅转介少数患者,主要是因为无法获得临床试验信息,以及缺乏足够的信息和时间来评估并自信地与患者讨论临床试验选择。
选择不转介患者的许多原因似乎是可以解决的,特别是通过有效的但目前未充分利用的沟通方式,利用社交媒体社区,并使用联络人作为临床护理和临床研究之间的桥梁。